| |
| |
|
| Insider
Information: |
Bell Leonard |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
390,670 |
|
|
Indirect Shares
|
403,285 |
|
|
| Direct
Value |
$71,297,275 |
|
|
|
Indirect Value
|
$73,599,513 |
|
|
| Total
Shares |
793,955 |
|
|
| Total
Value |
$144,896,788 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-03-01 |
390,670 |
2017-01-09 |
403,285 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
283 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2005-08-01 |
4 |
AS |
$26.05 |
$130,352 |
D/D |
(5,000) |
293,395 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2005-08-01 |
4 |
D |
$26.24 |
$110,916 |
D/D |
(4,227) |
289,168 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2005-08-01 |
4 |
OE |
$10.00 |
$160,930 |
D/D |
16,093 |
300,261 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2007-03-26 |
4 |
AS |
$44.26 |
$866,611 |
D/D |
(19,580) |
383,644 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2007-03-26 |
4 |
OE |
$10.38 |
$311,400 |
D/D |
30,000 |
403,224 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2007-11-15 |
4 |
AS |
$73.10 |
$615,495 |
D/D |
(8,400) |
387,244 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2007-11-15 |
4 |
OE |
$9.00 |
$108,000 |
D/D |
12,000 |
395,644 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2007-12-17 |
4 |
OE |
$9.00 |
$108,000 |
D/D |
12,000 |
399,244 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2007-12-17 |
4 |
OE |
$74.00 |
$22,200 |
D/D |
300 |
398,344 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2007-12-17 |
4 |
AS |
$73.90 |
$598,042 |
D/D |
(8,090) |
390,854 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2008-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
400,854 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2008-02-12 |
4 |
OE |
$9.00 |
$108,000 |
D/D |
12,000 |
412,854 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2008-02-12 |
4 |
AS |
$70.01 |
$601,386 |
D/D |
(8,590) |
404,264 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2008-02-15 |
4 |
AS |
$70.01 |
$601,386 |
D/D |
(8,590) |
407,674 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2008-02-15 |
4 |
OE |
$9.00 |
$108,000 |
D/D |
12,000 |
416,264 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2008-04-23 |
4 |
OE |
$9.00 |
$108,000 |
D/D |
12,000 |
419,674 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2008-04-23 |
4 |
AS |
$70.00 |
$601,300 |
D/D |
(8,590) |
411,084 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-01-12 |
4 |
S |
$34.44 |
$46,150 |
D/D |
(1,340) |
820,828 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-01-16 |
4 |
S |
$36.89 |
$184,339 |
D/D |
(4,997) |
815,831 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
21,000 |
836,831 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-02-26 |
4 |
OE |
$38.56 |
$220,370 |
D/D |
5,715 |
831,116 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-02-26 |
4 |
D |
$36.98 |
$362,182 |
D/D |
(9,794) |
821,322 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-02-26 |
4 |
OE |
$4.75 |
$95,000 |
D/D |
20,000 |
841,322 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-03-10 |
4 |
S |
$32.34 |
$37,967 |
D/D |
(1,174) |
840,148 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-03-16 |
4 |
S |
$34.25 |
$289,584 |
D/D |
(8,455) |
831,693 |
0 |
- |
|
283 Records found
|
|
Page 1 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
